Last Posted: Jan 07, 2020
- New PARP Inhibitor Approval for Pancreatic Cancer
L Schlager, FORCE, January 6, 2020 - Risk Assessment and Genetic Testing for Inherited Gastrointestinal Syndromes.
Stoll Jessica et al. Gastroenterology & hepatology 2019 Sep 15(9) 462-470 - Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice?
Krepline Ashley N et al. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2019 Nov - MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud Afra Z et al. BMC cancer 2019 Nov 19(1) 1130 - Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.
King Elisabeth et al. Clinical journal of oncology nursing 2019 Dec 23(6) 579-582 - Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk.
Underhill Meghan L et al. Journal of cancer education : the official journal of the American Association for Cancer Education 2019 Nov - Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers.
Matsubayashi Hiroyuki et al. Diagnostics (Basel, Switzerland) 2019 Oct 9(4) - Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Goggins Michael et al. Gut 2019 Oct - Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program.
Dwarte Tanya et al. Hereditary cancer in clinical practice 2019 1730 - CMS Aims to Broaden Coverage for NGS Testing in Breast, Ovarian Cancer -Expansion would include patients with risk factors for inherited susceptibility mutations
I Ingram, MedPage Today, October 31, 2019
.png)
No hay comentarios:
Publicar un comentario